Last updated on April 2016

A Phase III, Multicenter, Randomized, Double-blind, Double-dummy, Active-controlled Study Comparing the Efficacy and Safety of gastric Retentive, Controlled Release Accordion Pill™ Carbidopa/Levodopa (AP-CD/LD) to Immediate Release CD/LD in Fluctuating Parkinson's Disease Patients


Brief description of study

A Phase III, Multicenter, Randomized, Double-blind, Double-dummy, Active-controlled Study Comparing the Efficacy and Safety of gastric Retentive, Controlled Release Accordion Pill™ Carbidopa/Levodopa (AP-CD/LD) to Immediate Release CD/LD in Fluctuating Parkinson's Disease Patients

Detailed Study Description

This research study will assess the safety, tolerability and effectiveness of Accordion Pill Carbidopa/Levodopa (AP-CD/LD) compared to Immediate Release Carbidopa/Levodopa (IR CD/LD) (Sinemet) in patients with fluctuating Parkinson’s Disease (PD).

Clinical Study Identifier: TX143228

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Leigh Donharl

USF Health Byrd Alzheimer's Institute
Tampa, FL USA
  Connect »